Clinical Trial Update: Pharmacokinetic Interaction of Darapladib and CYP 3A4 in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating the interaction between darapladib and the CYP3A4 enzyme in healthy volunteers to assess potential drug-drug interactio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis

Drugs mentioned

• Darapladib (darapladib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Atherosclerosis | Phase 1 | Status: COMPLETED